[1]胡艳, 何倩, 马艳华, 等.病毒性肝炎患者血清肿瘤坏死因子及其可溶性受体的临床意义[J].武警医学, 2002, 13 (3) ∶134-137.
|
[2]温韬, 吴昊.白细胞介素12及其在抗HIV感染中的研究进展[J].国外医学 (流行病学传染病学分册) , 2003, 30 (5) ∶271-274.
|
[3]孙永年, 龚守军, 徐斌.乙肝血清白细胞介素6、白细胞介素8的检测及临床意义[J].武警医学, 2001, 12 (10) ∶602-603.
|
[4]MiLich DR, Stanleyf W.IL-12 suppresses autoantibody productionby riversing helper Tcell phenotype in hepatitis B e antigen transgen-ic mice[J].Proc Natl Acad Sci USA, 1999, 92∶6847-6851.
|
[5]成军.白细胞介素12在抗病毒治疗中的应用[J].国外医学 (流行病学传染病学分册) , 1999, 23 (1) ∶1-4.
|
[6]杨少奇, 王豪.白细胞介素-12在治疗病毒性肝炎中的作用[J].中华肝脏病杂志, 1999, 7 (3) ∶142~143.
|
[7]Lin RS, Lee Fy, Lee SD, et al.Endotoxemia in patients with chron-ic Liver diseases:relationship to severity of liver diseases, presenceof esophageal varices and hyperdymanic circulation[J].J Hepatol, 2003, 22∶165-172.
|
[8]胡艳, 欧阳少霞, 万洁.病毒性肝炎患者血清白细胞介素12的检测及临床意义[J].实用临床医学杂志, 2007, 8 (2) ∶13-15.
|
[1] | Ding Tao, Wei Jian, He XuDong. Lamivudine antiviral treatment after radical surgery prolongs disease-free survival of patients with hepatitis B virus-related liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(8): 1497-1501. doi: 10.3969/j.issn.1001-5256.2017.08.017 |
[2] | Wang Wei, Zheng HuanWei, Ren GuiFang, Feng AiDong, Liu Lian, Li BingShun. Differential profiles of T-cell subsets are present in peripheral blood of patients with various progressive forms of hepatitis B infection[J]. Journal of Clinical Hepatology, 2013, 29(4): 276-279. |
[3] | Feng XianNi. The therapeutic efficacy of Mannatide Tablets in the treatment of Lamivudine-resistant chronic hepatitis B[J]. Journal of Clinical Hepatology, 2010, 26(2): 180-181. |
[4] | Yan ShuangHuan, Chen CuiYing, Cao ZhiChen, Liu JinXia. Changes in peripheral T-lymphocytes subsets and CD28 subsets in patients with chronic HBV infected[J]. Journal of Clinical Hepatology, 2009, 25(5): 328-330. |
[5] | Zhao Shuang, Yan XueBing, Wang JinZhang, Hao JunGui, Wang MingShan, Feng Xia, Wan MeiRong. The study on imblance of cytotoxic T cells subtype (Tc1/Tc2) in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(6): 417-419. |
[7] | Xin YongNing, Zhao Hong, Ji ZhiPing, Wan Ying, Bi QuanXin, Zhu XiaoLan. Therapeutic effect of combined therapy of hepatocyte growth-promoting factor and salviate milttiorrhize on chronic hepatitis B[J]. Journal of Clinical Hepatology, 2005, 21(1): 25-26. |
[8] | Zhang ZhaoHua, Qin LaiYing, Liu KuiHua, Wang Lei, Wang YaoZong. The Effects of Early Viral Response (EVR) on The Treatment of Chronic Hepatitis B with Lamivudine[J]. Journal of Clinical Hepatology, 2005, 21(3): 155-156. |
[9] | Zhang Biao, Sui Tao, Yu XiuYing, Cao YongXian, Yao Yuan, He Hong. Significance of detecting apoptosis of PBMC and cytokine of supernatant induced by PHA in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(3): 138-140. |
[10] | Liu Fang, Li XiuPing, Zhang SuHuan, Li BingShun, Liu JinXing. Influence of serum TGF-β1 on cellular immune function in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(6): 335-337. |
[14] | He DongGou, Chen BoMing, Lin YongPing. Research of T lymphocyte subtypes and the phagocytosis activity of macrophages in the patients with virul hepatitis[J]. Journal of Clinical Hepatology, 2000, 16(1): 30-31. |